Contrary to the concern that bivalent antibodies may activate the targeted RTKs, in this report, we found that glioblastoma cells have an unusual high activity of HGF-induced MET receptor recycling with very few MET molecules get downregulated after HGF stimulation. This evidence concerns the gene MET and glioblastoma.